selicrelumab
Showing 1 - 4 of 4
Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in France (Selicrelumab, Atezolizumab)
Terminated
- Recurrent B-Cell Non-Hodgkin Lymphoma
- Refractory B-Cell Non-Hodgkin Lymphoma
- Selicrelumab
- Atezolizumab
-
Créteil, France
- +4 more
Jul 23, 2021
Advanced/Metastatic Solid Tumors Trial in Worldwide (Selicrelumab, Vanucizumab, Bevacizumab)
Completed
- Advanced/Metastatic Solid Tumors
- Selicrelumab
- +2 more
-
Los Angeles, California
- +15 more
Apr 3, 2020